Search
Now showing items 1-1 of 1
| Title | Author | Publication Date | Publisher | Type |
|---|---|---|---|---|
| CTLA4-Ig (abatacept): a promising investigational drug for use in type 1 diabetes. | 2020 | Taylor & Francis | Article Review |
Home
Submit your QU affiliated work
Browse
My Account
Discover
Author
Type
Subject
-
Abatacept (1)
autoimmune disease (1)
- beta cells (1) CTLA4-Ig (1) ... View More